Letter to Editor on "A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India"

Detalles Bibliográficos
Autores principales: Khuntia, Bharat Krushna, Agarwal, Aman, Sharma, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040503/
https://www.ncbi.nlm.nih.gov/pubmed/35487344
http://dx.doi.org/10.1016/j.ctim.2022.102838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040503/
https://www.ncbi.nlm.nih.gov/pubmed/35487344
http://dx.doi.org/10.1016/j.ctim.2022.102838

Ejemplares similares